Parmar D - Search Results

1

Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial.

Gawrieh S, Noureddin M, Loo N, Mohseni R, Awasty V, Cusi K, Kowdley KV, Lai M, Schiff E, Parmar D, Patel P, Chalasani N. Gawrieh S, et al. Among authors: parmar d. Hepatology. 2021 Oct;74(4):1809-1824. doi: 10.1002/hep.31843. Epub 2021 Jul 19. Hepatology. 2021. PMID: 33811367 Clinical Trial.

2

Effect of Food on the Pharmacokinetics of Saroglitazar Magnesium, a Novel Dual PPARαγ Agonist, in Healthy Adult Subjects.

Patel MR, Kansagra KA, Parikh DP, Parmar DV, Patel HB, Soni MM, Patil US, Patel HV, Patel JA, Gujarathi SS, Parmar KV, Srinivas NR. Patel MR, et al. Clin Drug Investig. 2018 Jan;38(1):57-65. doi: 10.1007/s40261-017-0584-2. Clin Drug Investig. 2018. PMID: 29022212 Clinical Trial.

3

New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.

Kaul U, Parmar D, Manjunath K, Shah M, Parmar K, Patil KP, Jaiswal A. Kaul U, et al. Among authors: parmar d, parmar k. Cardiovasc Diabetol. 2019 Jun 17;18(1):80. doi: 10.1186/s12933-019-0884-3. Cardiovasc Diabetol. 2019. PMID: 31208414 Free PMC article. Review.

4

Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study.

Rastogi A, Dunbar RL, Thacker HP, Bhatt J, Parmar K, Parmar DV. Rastogi A, et al. Acta Diabetol. 2020 Jul;57(7):809-818. doi: 10.1007/s00592-020-01487-8. Epub 2020 Feb 6. Acta Diabetol. 2020. PMID: 32030508 Clinical Trial.

5

Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study).

Krishnappa M, Patil K, Parmar K, Trivedi P, Mody N, Shah C, Faldu K, Maroo S; PRESS XII study group; Parmar D. Krishnappa M, et al. Among authors: parmar d, parmar k. Cardiovasc Diabetol. 2020 Jun 19;19(1):93. doi: 10.1186/s12933-020-01073-w. Cardiovasc Diabetol. 2020. PMID: 32560724 Free PMC article. Clinical Trial.

6

A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis.

Siddiqui MS, Idowu MO, Parmar D, Borg BB, Denham D, Loo NM, Lazas D, Younes Z, Sanyal AJ. Siddiqui MS, et al. Among authors: parmar d. Clin Gastroenterol Hepatol. 2021 Dec;19(12):2670-2672. doi: 10.1016/j.cgh.2020.10.051. Epub 2020 Nov 2. Clin Gastroenterol Hepatol. 2021. PMID: 33152542 Clinical Trial.

7

A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis.

Vuppalanchi R, González-Huezo MS, Payan-Olivas R, Muñoz-Espinosa LE, Shaikh F, Pio Cruz-Lopez JL, Parmar D. Vuppalanchi R, et al. Among authors: parmar d. Clin Transl Gastroenterol. 2021 Mar 26;12(4):e00327. doi: 10.14309/ctg.0000000000000327. Clin Transl Gastroenterol. 2021. PMID: 33769355 Free PMC article.

8

Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis.

Vuppalanchi R, Caldwell SH, Pyrsopoulos N, deLemos AS, Rossi S, Levy C, Goldberg DS, Mena EA, Sheikh A, Ravinuthala R, Shaikh F, Bainbridge JD, Parmar DV, Chalasani NP. Vuppalanchi R, et al. Among authors: parmar dv. J Hepatol. 2022 Jan;76(1):75-85. doi: 10.1016/j.jhep.2021.08.025. Epub 2021 Sep 4. J Hepatol. 2022. PMID: 34487750 Clinical Trial.

9

Estimation of ZYKR1 in human urine and plasma utilizing LC-MS/MS positive electrospray ionization; a kappa opioid receptor (KOR) agonist.

Ghoghari A, Bhatt C, Patel K, Jha A, Patel H, Jain M, Momin T, Parmar D, Patel P. Ghoghari A, et al. Among authors: parmar d. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Nov 15;1185:122982. doi: 10.1016/j.jchromb.2021.122982. Epub 2021 Oct 24. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 34731743

10

Saroglitazar is noninferior to fenofibrate in reducing triglyceride levels in hypertriglyceridemic patients in a randomized clinical trial.

Rodriguez-Gutierrez R, González JG, Parmar D, Shaikh F, Cruz-López P. Rodriguez-Gutierrez R, et al. Among authors: parmar d. J Lipid Res. 2022 Jul;63(7):100233. doi: 10.1016/j.jlr.2022.100233. Epub 2022 May 21. J Lipid Res. 2022. PMID: 35605678 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

487 results

Search Page